Association between the methylation of CpG islands in JAK-STAT pathway-related genes and colorectal cancer
Copyright © 2023. Published by Elsevier B.V..
BACKGROUND: Aberrant promoter methylation of CpG islands plays an important role in carcinogenesis. However, the association between the DNA methylation of JAK-STAT pathway-related genes in peripheral blood leukocytes and colorectal cancer (CRC) susceptibility remains unclear.
METHODS: We conducted a case-control study of 403 patients with CRC and 419 cancer free controls, and the DNA methylation levels of JAK2, STAT1, STAT3, and SOCS3 in peripheral blood samples from all subjects were assessed using a methylation-sensitive high-resolution melting (MS-HRM) analysis.
RESULTS: Compared with controls, the methylation of the JAK2, STAT1 and SOCS3 genes increased the CRC risk (ORadjusted=1.96, 95% CI, 1.12-3.41, P=0.01; ORadjusted=5.37, 95% CI, 3.74-7.71, P<0.01; ORadjusted=3.30, 95% CI, 1.58-6.87, P<0.01). In the multiple CpG site methylation (MCSM) analysis, a high MCSM value denoted an increased CRC risk (ORadjusted=4.97, 95% CI, 3.34-7.37, P<0.01).
CONCLUSION: In peripheral blood, the methylation of JAK2, STAT1, and high levels of MCSM are promising biomarkers for CRC risk.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:868 |
---|---|
Enthalten in: |
Gene - 868(2023) vom: 05. Juni, Seite 147357 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Rong, Jiesheng [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 01.05.2023 Date Revised 01.05.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.gene.2023.147357 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM354197290 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM354197290 | ||
003 | DE-627 | ||
005 | 20231226061710.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.gene.2023.147357 |2 doi | |
028 | 5 | 2 | |a pubmed24n1180.xml |
035 | |a (DE-627)NLM354197290 | ||
035 | |a (NLM)36914143 | ||
035 | |a (PII)S0378-1119(23)00198-1 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Rong, Jiesheng |e verfasserin |4 aut | |
245 | 1 | 0 | |a Association between the methylation of CpG islands in JAK-STAT pathway-related genes and colorectal cancer |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.05.2023 | ||
500 | |a Date Revised 01.05.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023. Published by Elsevier B.V. | ||
520 | |a BACKGROUND: Aberrant promoter methylation of CpG islands plays an important role in carcinogenesis. However, the association between the DNA methylation of JAK-STAT pathway-related genes in peripheral blood leukocytes and colorectal cancer (CRC) susceptibility remains unclear | ||
520 | |a METHODS: We conducted a case-control study of 403 patients with CRC and 419 cancer free controls, and the DNA methylation levels of JAK2, STAT1, STAT3, and SOCS3 in peripheral blood samples from all subjects were assessed using a methylation-sensitive high-resolution melting (MS-HRM) analysis | ||
520 | |a RESULTS: Compared with controls, the methylation of the JAK2, STAT1 and SOCS3 genes increased the CRC risk (ORadjusted=1.96, 95% CI, 1.12-3.41, P=0.01; ORadjusted=5.37, 95% CI, 3.74-7.71, P<0.01; ORadjusted=3.30, 95% CI, 1.58-6.87, P<0.01). In the multiple CpG site methylation (MCSM) analysis, a high MCSM value denoted an increased CRC risk (ORadjusted=4.97, 95% CI, 3.34-7.37, P<0.01) | ||
520 | |a CONCLUSION: In peripheral blood, the methylation of JAK2, STAT1, and high levels of MCSM are promising biomarkers for CRC risk | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Colorectal cancer | |
650 | 4 | |a Interactive effect | |
650 | 4 | |a JAK-STAT | |
650 | 4 | |a Methylation | |
650 | 4 | |a Peripheral blood | |
650 | 7 | |a Janus Kinases |2 NLM | |
650 | 7 | |a EC 2.7.10.2 |2 NLM | |
650 | 7 | |a STAT Transcription Factors |2 NLM | |
650 | 7 | |a Biomarkers, Tumor |2 NLM | |
650 | 7 | |a Suppressor of Cytokine Signaling Proteins |2 NLM | |
700 | 1 | |a Pu, Rui |e verfasserin |4 aut | |
700 | 1 | |a Sun, Hongru |e verfasserin |4 aut | |
700 | 1 | |a Liu, Yupeng |e verfasserin |4 aut | |
700 | 1 | |a Tian, Tian |e verfasserin |4 aut | |
700 | 1 | |a Bi, Haoran |e verfasserin |4 aut | |
700 | 1 | |a Xia, Tingting |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Lei |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Yuanyuan |e verfasserin |4 aut | |
700 | 1 | |a Zhao, Yashuang |e verfasserin |4 aut | |
700 | 1 | |a Zhu, Lin |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Gene |d 1979 |g 868(2023) vom: 05. Juni, Seite 147357 |w (DE-627)NLM000233951 |x 1879-0038 |7 nnns |
773 | 1 | 8 | |g volume:868 |g year:2023 |g day:05 |g month:06 |g pages:147357 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.gene.2023.147357 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 868 |j 2023 |b 05 |c 06 |h 147357 |